A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

NCT03347370 · clinicaltrials.gov ↗

COMPLETED

Status

626

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: SC Peginterferon beta-1a
DRUG: SC interferon beta-1a
DRUG: SC interferon beta-1b

Sponsor

Biogen

Collaborators

[object Object]